SLC5A2 and aortic stenosis: Similarly, in patients with severe AS, reduced left ventricular ejection fraction, and extra-valvular cardiac damage undergoing transcatheter aortic valve implantation (TAVI), the use of SGLT2 inhibitors was associated with improved left ventricular recovery and reduced adverse cardiovascular events.